61 – 70 of 247
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register
(
- Contribution to journal › Article
-
Mark
S100A8/A9 in bleomycin-induced skin fibrosis
2011) 31st European Workshop for Rheumatology Research In Annals of the Rheumatic Diseases 70(Suppl. 2).(
- Contribution to journal › Published meeting abstract
-
Mark
Antibody response is reduced following vaccination with 7-valent conjugate pneumococcal vaccine in adult methotrexate-treated patients with established arthritis, but not those treated with tumor necrosis factor inhibitors
(
- Contribution to journal › Article
-
Mark
Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis
(
- Contribution to journal › Article
-
Mark
Long-term mortality rate in rheumatoid arthritis patients with disease onset in the 1980s.
(
- Contribution to journal › Article
-
Mark
The role of the cartilage matrix in osteoarthritis.
(
- Contribution to journal › Article
-
Mark
The number needed to treat for second-generation biologics when treating established rheumatoid arthritis: a systematic quantitative review of randomized controlled trials.
(
- Contribution to journal › Article
-
Mark
National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients.
(
- Contribution to journal › Article
-
Mark
Ten years with biologics: to whom do data on effectiveness and safety apply?
(
- Contribution to journal › Article
-
Mark
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis.
(
- Contribution to journal › Article